Clinical Pharmacology of FYU-981 (Final Formulation)

Summary

This is a randomized, open-label, 2-period crossover study. The purpose of this study is to assess the pharmacokinetics and safety after single oral administration of final formulation of FYU-981 to healthy male adults in fasted and fed conditions. Participants are randomized to fasted (n=6) or fed conditions (n=6) in each step. The effect of food to pharmacokinetics of FYU-981 is also investigated.

Timeline

Start

2017-11-06

Primary completion

2017-11-29

Completion

2017-11-29

Drugs

Indications

No indication recorded.